
disease areas
Improving diagnostic accuracy.
Improving diagnostic accuracy.
To help improve the diagnosis of APS, we’ve introduced QUANTA Lite® PS/PT. This new assay is designed to increase the sensitivity in the diagnosis of APS without sacrificing specificity. It can help confirm a diagnosis even when a patient has already started anti-coagulation treatment. When used in combination with other markers, it offers insights for risk assessment related to thrombotic events and recurring pregnancy loss.
HIGHLIGHTS
- Improved patient care.Patients need not interrupt anticoagulation therapy for an accurate diagnosis of APS.
- Aid in clinical assessments.QUANTA Lite PS/PT assays deliver optimal results when used in combination with other QUANTA Lite APS tests – helping physicians diagnose APS quickly and confidently.
Reagents
Description
Part Number
Lot number
Documents
Description
Part Number
Lot number
Documents
Related Systems

QUANTA-Lyser® 3000
QUANTA-Lyser® 3000
QUANTA-Lyser 3000 is a high throughput EIA/IFA that give you the ability to complete your workload faster with less hands-on time.

QUANTA-Lyser® 160/240 EIA/IFA Processors
QUANTA-Lyser® 160/240 EIA/IFA Processors
Flexible EIA/IFA processing platform to meet the volume requirements of your laboratory

QUANTA-Lyser® 2
QUANTA-Lyser® 2
QUANTA-Lyser® 2 is the ideal platform for esoteric assays or in settings that require maximum flexibility and efficiency

BIO-FLASH®
BIO-FLASH®
Autoimmune chemiluminescent (CIA) analyzer eliminates batching and provides precise quantification.